Synlogic (SYBX) Cash per Single Share

Synlogic Inc. - graphic logo of issuer SYBX

Synlogic, Inc. (SYBX) focuses on the monetization of synthetic biology and asset restructuring. Fluctuations in cash per share, with GURU.Markets data illustrated on this chart, demonstrate capital liquidity, while 1.32 captures the current state of the parameter. Experts in "living" medicines drive development, while the environmental profile is limited to basic bio-waste disposal and green offices.

Synlogic Inc. (SYBX) Cash per Single Share: for the period 07/04/2022 - 01/24/2026

Analytical breakdowns for Synlogic, Inc.

- market value and analyst target forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:SYBX (Synlogic)
Product sample of Synlogic Corp

Long-term capital requires strict liquidity control to minimize bankruptcy risks. For Synlogic, Inc. (SYBX), which creates programmable bacteria, maintaining reserves is critical due to the high cost of bioengineering development. Data on highly liquid assets per share is determined by dividing the cash balance by the number of securities. This metric reflects the business's real margin of safety per share. An increase in this indicator confirms the financial autonomy of this synthetic biology innovator.